Construction of a fusion protein expression vector MK-EGFP and its subcellular localization in different carcinoma cell lines

World Journal of Gastroenterology

Volumn 12, Issue 47, 2006, Pages 7649-7653

  Dai, Li Cheng ^a   Xu, Di Yong ^b   Yao, Xing ^a   Min, Li Shan ^a   Zhao, Ning ^a   Xu, Bo Ying ^c   Xu, Zheng Ping ^b   Lu, Yong Liang ^a  

^a HUZHOU CENTRAL HOSPITAL   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c HUZHOU UNIVERSITY   (China)

Author keywords

Laser scanning confocal microscopy; Midkine; Subcellular localization

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MIDKINE; RECOMBINANT PROTEIN; RIBOSOME RNA; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; CARCINOMA CELL; CELL NUCLEUS; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EXPRESSION VECTOR; FLUORESCENCE ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOLUS; PLASMID VECTOR; PROTEIN ASSEMBLY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RNA TRANSCRIPTION;

EID: 33846021590     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i47.7649     Document Type: Article

References (26)

1. Koide N, Hada H, Shinji T, Ujike K, Hirasaki S, Yumoto, Y, Hanafusa T, Kadomatsu K, Muramatsu H, Muramatsu T, Tsuji T. Expression of the midkine gene in human hepatocellular carcinomas. Hepatogastroenterology 1999; 46: 3189-3196
2. Aridome K, Tsutsui J, Takao S, Kadomatsu K, Ozawa M, Aikou T, Muramatsu T. Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res 1995; 86: 655-661
3. Garver RJr, Radford DM, Donis-Keller H, Wick MR, Milner PG. Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 1994; 74: 1584-1590
4. Ye C, Qi M, Fan QW, Ito K, Akiyama S, Kasai Y, Matsuyama M, Muramatsu T, Kadomatsu K. Expression of midkine in the early stage of carcinogenesis in human colorectal cancer. Br J Cancer 1999; 79: 179-184
5. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res. 1996; 56: 2515-2518
6. Muramatsu H, Shirahama H, Yonezawa S, Maruta H, Muraatsu T. Midkine a retinoic acid-inducible growth/ differentiation factor: immunochemical evidence for the function and distribution. Dev Biol 1993; 159: 392-402
7. Muramatsu H, Muramatsu T. Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors. Biochem Biophys Res Commun 1991; 177: 652-658
8. Kadomatsu K, Hagihara M, Akhter S, Fan QW, Muramatsu H, Muramatsu T. Midkine induces the transformation of NIH3T3 cells. Br J Cancer 1997; 75: 354-359
9. Qi M, Ikematsu S, Ichihara-Tanaka K, Sakuma S, Muramatsu T, Kadomatsu K. Midkine rescues Wilm's tumor cells from cisplatin-induced apoptosis: regulation of Bcl-2 expression by Midkine. J Biochem (Tokyo) 2000; 127: 269-277
10. Choudhuri R, Zhang HT, Donnini S, Ziche M, Bicknell R. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res 1997; 57: 1814-1819.
11. Rha SY, Noh SH, Kwak HJ, Wellstein A, Kim JK Roh JK, Min JS, Kim BS, Chung HC. Comparison of biological phenotypes according to midkine expression in gastric cancer cells and their autocrine activities could be modulated by pentosan polysulfate. Cancer Lett 1997; 118: 37-46
12. Ikematsu S, Yano A, Aridome K, Kikuchi M, Kumai H, Nagano H, Okamoto K, Oda M, Sakuma S, Aikou T, Muramatsu H, Kadomatsu K, Muramatsu T. Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer 2000; 83: 701-706
13. Rha SY, Noh SH, Kim TS, Yoo NC, Roh JK, Min JS, Kim BS. Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer. Int J Mol Med 1999; 4: 203-212
14. Aridome K, Takao S, Kaname T, Kadomatsu K, Natsugoe S, Kijima F, Aikou T, Muramatsu T. Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas. Br J Cancer 1998; 78: 472-477
15. Ono HA, Davydova JG, Adachi Y, Takayama K, Barker SD, Reynolds PN, Krasnykh VN, Kunisaki C, Shimada H, Curiel DT, Yamamoto M. Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer. J Gastroenterol 2005; 40: 31-42
16. Salama RH, Muramatsu H, Zou K, Inui T, Kimura T, Muramatsu T. Midkine binds to 37-kDa laminin binding protein precursor, leading to nuclear transport of the complex. Exp Cell Res 2001; 270: 13-20
17. Shibata Y, Muramatsu T, Hirai M, Inui T, Kimura T, Saito H, McCormick LM, Bu G, Kadomatsu K. Nuclear targeting by the growth factor midkine. Mol Cell Biol 2002; 22: 6788-6796
18. Suzuki N, Shibata Y, Urano T, Murohara T, Muramatsu T, Kadomatsu K. Proteasomal degradation of the nuclear targeting growth factor midkine. J Biol Chem 2004; 279: 17785-17791
19. Callebaut C, Nisole S, Briand JP, Krust B, Hovanessian AG. Inhibition of HIV infection by the cytokine midkine. Virology 2001; 281: 248-264
20. Bellas RE, FitzGerald MJ, Fausto N, Sonenshein GE. Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes. Am J Pathol 1997; 151: 891-896
21. Heyninck K, Kreike MM, Beyaert R. Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1. FEBS Lett 2003; 536: 135-140
22. Nair A, Venkatraman M, Maliekal TT, Nair B, Karunagaran D. NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 2003; 22: 50-58
23. Lorang JM, Tuori RP, Martinez JP, Sawyer TL, Redman RS, Rollins JA, Wolpert TJ, Johnson KB, Rodriguez RJ, Dickman MB, Ciuffetti LM. Green fluorescent protein is lighting up fungal biology. Appl Environ Microbiol 2001; 67: 1987-1994
24. Imamoto N. Diversity in nucleocytoplasmic transport pathways. Cell Struct Funct 2000; 25: 207-216
25. Jans DA, Xiao CY, Lam MH. Nuclear targeting signal recognition: a key control point in nuclear transport? Bioessays 2000; 22: 532-544
26. Jans DA, Hassan G. Nuclear targeting by growth factors, cytokines, and their receptors: a role in signaling? Bioessays 1998; 20:400-411